文献速递细胞病理与分子病理

甲状腺Hürthle细胞肿瘤的分子改变:细针穿刺细胞学研究与细胞学-组织学对照

Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation.
PubMed 文献 · Cancer Cytopathol · 2020-10-12

该研究回顾性分析了2017年至2020年279例细胞学诊断为Hürthle细胞肿瘤(HCN)的病例,其中85例有分子检测结果。恶性病例中80%(8/10)存在分子改变,最常见为染色体拷贝数改变(n=15),其次为NRAS(n=8)、KRAS(n=7)等。HCN总体恶性风险为20%,伴分子改变者恶性风险为25%。

要点

  • HCN细胞学诊断中分子改变多样,无单一主导趋势。
  • 恶性HCN多数(80%)携带某种分子改变。
  • HCN总体恶性风险20%,伴分子改变者25%。

核心结论

  • 细胞学诊断HCN包含多种分子改变且无明确趋势,大多数恶性病例(80%)具有某种分子改变。

研究设计与样本

  • 回顾性研究,检索2017年1月1日至2020年3月31日电子数据库中的HCN细胞学诊断病例。

主要发现

  • 10例恶性病例中8例有分子改变,2例无分子改变。
  • 最常见的分子改变为染色体拷贝数改变(n=15),其次为NRAS(n=8)、KRAS(n=7)、可疑分类(n=6)、EIF1AX(n=4)、TSHR(n=3)、基因过表达(n=3)、阳性microRNA分类器(n=2),以及BRAF K601E、TERT、HRAS突变各1例。
  • HCN总体恶性风险为20%,伴分子改变的HCN恶性风险为25%。

临床怎么用

  • 细胞学诊断为HCN时,分子检测可辅助评估恶性风险,但分子改变谱多样,需结合组织学随访。

局限性

  • 回顾性研究,分子检测结果仅在部分病例中可用(85/279),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hürthle cell features are frequently observed on the fine-needle aspiration (FNA) cytology of thyroid nodules and often pose a diagnostic challenge because of a significant overlap between cytomorphologic features seen in benign and malignant lesions. Molecular alterations (MAs) associated with these lesions are not well described. The objective of the current study was to evaluate the molecular profile of Hürthle cell lesions classified as Hürthle cell neoplasm (HCN) on cytologic evaluation. METHODS: The authors retrospectively reviewed their electronic database for cytologic diagnoses of HCN from January 1, 2017 to March 31, 2020. RESULTS: In total, 279 cases from 275 patients who had a diagnosis of HCN were included in the study. Molecular testing results were available in 85 cases (51 with MAs and 34 without MAs) and, of those, 42 had histologic follow-up available. Eight of 10 malignant cases had MAs, whereas the remaining 2 cases were negative for MAs. The most frequently encountered predominant genetic alterations or classifier findings were chromosome copy number alterations (n = 15), followed by NRAS (n = 8), KRAS (n = 7), suspicious (n = 6), EIF1AX (n = 4), TSHR (n = 3), gene overexpression (n = 3), positive microRNA classifier (n = 2), and 1 each of BRAF K601E, TERT, and HRAS mutations. One hundred thirty-seven cases had histologic follow-up available; of those, 28 were classified as malignant, and 109 were classified as benign (neoplastic and nonneoplastic). The overall risk of malignancy associated with HCN was 20%, and the risk of HCN with MAs was 25%. CONCLUSIONS: The cytologic diagnosis of HCN includes various MAs without any obvious trend, and most malignant cases (80%) have some type of MA.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Gilani SM, Ross JA, Prasad ML, et al. Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation. Cancer Cytopathol. 2020. PMID: 33045146. doi:10.1002/cncy.22370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。